Premera

Does Premera cover Zepbound?

Quick answer · Weight Loss

Premera covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance.

  • Employer / Commercial Insurance: Covered with requirements. BMI of 30 or higher

Last verified June 3, 2026. Policy effective April 1, 2026. Source: 5.01.621.pdf. How we verify this data →

Check your card for your exact plan →

Zepbound for Weight Loss

What Premera requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (Asthma, CVD, COPD, Coronary artery disease, Dyslipidemia, HTN, Knee osteoarthritis, MASH/NAFLD, OSA, PCOS, and T2DM)
  • 3 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Adult weight management (18+) — BMI >= 30

All of:

  • Age >= 18 years
  • BMI >= 30 kg/m2
  • Trial of behavioral modification and dietary restriction for at least 3 months
  • Medication used as adjunct to reduced-calorie diet and increased physical activity
  • Dose limited to 15 mg once weekly
  • Quantity limited to 4 prefilled pens or single-dose vials per 28 days, OR 1 Kwikpen or multi-dose vial per 28 days
  • Not used concurrently with other weight loss medications

Adult weight management (18+) — BMI >= 27 with comorbidity

All of:

  • Age >= 18 years
  • BMI >= 27 kg/m2
  • Trial of behavioral modification and dietary restriction for at least 3 months
  • Medication used as adjunct to reduced-calorie diet and increased physical activity
  • Dose limited to 15 mg once weekly
  • Quantity limited to 4 prefilled pens or single-dose vials per 28 days, OR 1 Kwikpen or multi-dose vial per 28 days
  • Not used concurrently with other weight loss medications

Plus any one of:

  • Asthma
  • Cardiovascular disease
  • COPD
  • Coronary artery disease
  • Dyslipidemia
  • Hypertension
  • Knee osteoarthritis
  • Metabolic-dysfunction associated steatotic liver disease/non-alcoholic fatty liver disease
  • Obstructive sleep apnea
  • Polycystic ovarian syndrome
  • Type 2 diabetes mellitus

Documentation to bring

  • Office visit notes containing baseline body weight and BMI
  • Documentation of relevant history including any weight-related comorbidities
  • Documentation of dietary plan and physical activity plan
  • Documentation of at least 3-month trial of behavioral modification and dietary restriction
  • Medication dosage documentation

Quantity limits

  • 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg — 4 prefilled pens or single-dose vials per 28 days, OR 1 Kwikpen or multi-dose vial per 28 days

Approval and renewal

  • Initial approval: 7 months
  • Renewal: every 12 months
  • To renew, the plan looks for at least 5% weight loss from the starting weight, Adults: >=5% baseline body weight loss after 7 months of treatment AND able to tolerate Zepbound maintenance dose of up to 15 mg once weekly AND continues adherence to reduced-calorie diet and increased physical activity. Non-formulary exception reviews may be approved up to 12 months, at least 28 weeks on therapy before the first renewal, and staying on a maintenance dose of at least 15 mg. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Concurrent use with other weight loss medications (phentermine, phentermine/topiramate ER, benzphetamine, diethylpropion, phendimetrazine, Alli, Contrave, liraglutide 18 mg/3 mL pen, Qsymia, Saxenda, Xenical, Wegovy)
  • All uses other than FDA-approved dosage and administration are considered investigational
  • Coverage subject to benefit plan; many plans exclude weight management drugs
  • This medical policy does not apply to Medicare Advantage

Policy note: No pediatric indication listed for Zepbound weight management in this policy (adults 18+ only). Quantity limit updated in 2026 to distinguish prefilled pens/single-dose vials (4 per 28 days) from Kwikpen/multi-dose vials (1 per 28 days).

Policy effective April 1, 2026 · verified June 3, 2026 · source: 5.01.621.pdf

Zepbound for Osa

What Premera requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • Diagnosed obstructive sleep apnea (AHI of 15 or higher)

Qualification pathways

You can qualify through any one of these.

OSA indication — moderate to severe OSA in adults with obesity

All of:

  • Age >= 18 years
  • BMI >= 30 kg/m2
  • Sleep study within the past 12 months showing AHI >= 15 events per hour
  • NOT diagnosed with central sleep apnea with >= 50% central apneas/hypopneas
  • NOT diagnosed with Cheyne Stokes respiration
  • Medication used as adjunct to reduced-calorie diet and increased physical activity
  • Dose limited to 15 mg once weekly
  • Quantity limited to 4 prefilled pens or single-dose vials per 28 days, OR 1 Kwikpen or multi-dose vial per 28 days
  • Not used concurrently with other weight loss medications

Documentation to bring

  • Office visit notes containing baseline body weight and BMI (>= 30 kg/m2)
  • Sleep study results within the past 12 months documenting AHI >= 15 events per hour
  • Documentation confirming absence of central sleep apnea (>= 50% central apneas/hypopneas) and absence of Cheyne Stokes respiration
  • Medication dosage documentation

Quantity limits

  • 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg — 4 prefilled pens or single-dose vials per 28 days, OR 1 Kwikpen or multi-dose vial per 28 days

Approval and renewal

  • Initial approval: 12 months
  • Renewal: every 12 months
  • To renew, the plan looks for at least 10% weight loss from the starting weight, >=10% baseline body weight loss after 12 months of treatment AND stability in OSA signs or symptoms such as snoring, excessive daytime sleepiness, and fatigue AND continued adherence to reduced-calorie diet and increased physical activity AND baseline BMI >= 30 kg/m2 AND age >= 18 years, and at least 52 weeks on therapy before the first renewal. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Central sleep apnea with >= 50% of central apneas/hypopneas
  • Cheyne Stokes respiration
  • Concurrent use with other weight loss medications (phentermine, phentermine/topiramate ER, benzphetamine, diethylpropion, phendimetrazine, Alli, Contrave, liraglutide 18 mg/3 mL pen, Qsymia, Saxenda, Xenical, Wegovy)
  • All uses other than FDA-approved dosage and administration are considered investigational
  • Coverage subject to benefit plan; many plans exclude weight management drugs
  • This medical policy does not apply to Medicare Advantage

Policy note: OSA indication requires moderate-to-severe OSA (AHI >= 15 events/hour) confirmed by sleep study within 12 months. No PAP/CPAP trial required. Obesity (BMI >= 30) required — lower BMI threshold with comorbidity does not apply to this indication. Continuation requires >=10% weight loss after 12 months AND OSA symptom stability. Initial authorization is 12 months (same as non-formulary exception reviews).

Policy effective April 1, 2026 · verified June 3, 2026 · source: 5.01.621.pdf

Why Zepbound requests get denied by Premera

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).
  3. Qualifying weight-related condition not documented with its own diagnosis code.
  4. No documented diet and exercise program.
  5. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does Premera cover Zepbound?
Premera covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance.
What BMI do you need for Zepbound under Premera?
For weight loss on Employer / Commercial Insurance plans, Premera requires a BMI of 30 or higher, or 27 or higher with a qualifying weight-related condition.
How long does a Zepbound approval last with Premera?
Initial approvals last 7 months, and renewals are granted in 12-month periods.
What does Premera require to renew Zepbound?
At least 5% weight loss from the starting weight, Adults: >=5% baseline body weight loss after 7 months of treatment AND able to tolerate Zepbound maintenance dose of up to 15 mg once weekly AND continues adherence to reduced-calorie diet and increased physical activity. Non-formulary exception reviews may be approved up to 12 months, at least 28 weeks on therapy before the first renewal, and staying on a maintenance dose of at least 15 mg.
How current is this information?
This page reflects Premera's written policy as of April 1, 2026, last verified against the source document on June 3, 2026.

Other medications under Premera

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes Premera's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.